OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression
Danyu Du, Mengyao Qin, Li Shi, et al.
Oncogene (2023) Vol. 42, Iss. 42, pp. 3127-3141
Closed Access | Times Cited: 8
Danyu Du, Mengyao Qin, Li Shi, et al.
Oncogene (2023) Vol. 42, Iss. 42, pp. 3127-3141
Closed Access | Times Cited: 8
Showing 8 citing articles:
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Ding Nan, Weiping Yao, Luanluan Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Ding Nan, Weiping Yao, Luanluan Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis
Xiaobin Wang, Yingqing Shi, Hua Shi, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Xiaobin Wang, Yingqing Shi, Hua Shi, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
Chun Wang, Zhihang Chen, Yun Yi, et al.
Oncogene (2023) Vol. 43, Iss. 5, pp. 328-340
Closed Access | Times Cited: 11
Chun Wang, Zhihang Chen, Yun Yi, et al.
Oncogene (2023) Vol. 43, Iss. 5, pp. 328-340
Closed Access | Times Cited: 11
SLC13A2-transported citrate is a metabolic signal for PKM2 acetylation and degradation to suppress tumor growth
Mengyao Qin, Li Shi, Hao Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mengyao Qin, Li Shi, Hao Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Determination of Ligand-Target Interaction in vitro by Cellular Thermal Shift Assay and Isothermal Dose-response Fingerprint Assay
Danyu Du, Shengtao Yuan, Jing Xiong
BIO-PROTOCOL (2024) Vol. 14, Iss. 1350
Open Access | Times Cited: 1
Danyu Du, Shengtao Yuan, Jing Xiong
BIO-PROTOCOL (2024) Vol. 14, Iss. 1350
Open Access | Times Cited: 1
Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Dongling Jia, Zefei Jiang, Minhui Cui, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
RBM45: Molecular, Cellular, and Evolutionary Biology
Jeffrey O. Henderson
Journal of DNA And RNA Research (2024) Vol. 1, Iss. 2, pp. 31-43
Open Access
Jeffrey O. Henderson
Journal of DNA And RNA Research (2024) Vol. 1, Iss. 2, pp. 31-43
Open Access
